Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Rabbit anti-PTEN, Polyclonal, Novus Biologicals™

Rabbit Polyclonal Antibody

$199.00 - $329.00

Specifications

Antigen PTEN
Concentration 0.2mg/mL
Immunogen Recombinant full-length human PTEN protein
Gene Accession No. P60484
Gene ID (Entrez) 5728
View More Specs

Products 3
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
NBP24453801 View Documents Novus BiologicalsSupplier Diversity Partner
NBP2445380.1MG
0.1 mg Each for $329.00
Add to cart
 
NBP24453800 View Documents Novus BiologicalsSupplier Diversity Partner
NBP2445380.02MG
0.02 mg Each for $199.00
Add to cart
 
NBP24453802 View Documents Novus BiologicalsSupplier Diversity Partner
NBP2445380.2MG
0.2 mg This item has been discontinued and is no longer available. Please call customer service for assistance: 1-800-766-7000.
N/A
Description

Description

Specifically detects PTEN in Human, Mouse samples, and it is validated for Flow Cytometry, Immunofluorescence, Western Blotting

PTEN Polyclonal antibody specifically detects PTEN in Human, Mouse samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry-Paraffin, Immunofluorescence.
Specifications

Specifications

PTEN
Recombinant full-length human PTEN protein
5728
Polyclonal
Rabbit
IgG
Purified
RUO
0.2mg/mL
P60484
10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Primary
Recognizes a protein of 55kDa, which is identified as PTEN. PTEN is one of the most commonly lost tumor suppressors in human cancer; in fact, up to 70% of men with prostate cancer are estimated to have lost a copy of the PTEN gene at the time of diagnosis. During tumor development, mutations and deletions of PTEN occur that inactivate its enzymatic activity leading to increased cell proliferation and reduced cell death. Frequent genetic inactivation of PTEN occurs in glioblastoma, endometrial cancer, and prostate cancer; and reduced expression is found in many other tumor types such as lung and breast cancer. In breast and prostate cancer, loss of PTEN expression has been shown to correlate positively with advanced stage. Furthermore, PTEN mutation also causes a variety of inherited predispositions to cancer.
Unconjugated
Western Blot, Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence
Store at 4C.

For Research Use Only

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit